| BSE: 533157 | Sector: Health care |
| NSE: SYNCOM | ISIN Code: INE602K01014 |
| BSE 00:00 | 11 Feb | 0.79 |
0 (0.00%) |
OPEN
0.79 |
HIGH
0.79 |
LOW
0.79 |
| NSE 00:00 | 17 Feb | 0.65 |
0 (0.00%) |
OPEN
0.60 |
HIGH
0.65 |
LOW
0.60 |
| OPEN | 0.79 |
| PREVIOUS CLOSE | 0.79 |
| VOLUME | 1100 |
| 52-Week high | 2.63 |
| 52-Week low | 0.76 |
| P/E | |
| Mkt Cap.(Rs cr) | 3 |
| Buy Price | 0.76 |
| Buy Qty | 100.00 |
| Sell Price | 0.79 |
| Sell Qty | 900.00 |
Syncom Healthcare Ltd is engaged in the manufacture, marketing and trade of pharmaceutical formulations. The company manufactures a range of products such as Ethical drugs, Generic drugs, over the counter drugs (OTC) and Herbal formulations in various dosage forms and markets them under the trade mark, Syncom. The company also undertakes contract manufacturing for large variety of pharmaceutica...> More
| COMPANY INFORMATION | |||||||
| Independent Director : | Sunita Garg | ||||||
| Independent Director : | Tushar Patodia | ||||||
| Managing Director : | Ajay Shankarlal Bankda | ||||||
| Additional Director : | Manoj Negi | ||||||
| Company Secretary : | Farida Bhatia | ||||||
| Additional Director : | Bhishampal Singh Yadav | ||||||
| AUDITOR : | S G Kabra & Co | ||||||
| IND NAME : | Pharmaceuticals - Indian - Formulations | ||||||
| HOUSE NAME : | Indian Private | ||||||
| Registered office | |||||||
| 502 Advent Atria, Chincholi Bunder Road Malad(W),Mumbai,Maharashtra-400064 | |||||||
| Ph : 91-022-28813796/97 | |||||||
| WEBSITE : http://www.syncomhealthcare.com | |||||||
| E-mail : complianceofficer@syncom.in | |||||||
